Mieloma Multiple - Mieloma.com

Me mandaron por E.Mail  en Myeloma minute estas noticias..
("IMF Myeloma Minute" <minute@myeloma.org>)
Para leer más sobre esos temas, ir a Myeloma Minute - April 7, 2008.....

Cita:
 

"WHAT'S NEWS
---*Report Claims Clinical Trials Miss Many Populations
A new analysis of the American clinical trial process suggests that the system for testing new drugs has routinely excluded or under-represented women, older people, minorities, disabled individuals and rural populations for decades. (from US News and World Report)

---*TV drug ads should list FDA hotline, lawmakers say
Citing a new Consumer Reports poll, two members of Congress urged the FDA to mandate that all television advertising for prescription drugs include information for consumers to report serious side effects to the agency. The poll found that 16% of respondents who had taken a prescription drug had experienced a side effect serious enough to send them to the doctor or hospital, but only 35% were aware that such side effects could be reported to the FDA. (from the Los Angeles Times)

---*FDA Releases Five-Year Drug Safety Plan
The FDA has unveiled a five-year program aimed at employing more safety reviewers and risk-management and medication-error experts to improve post-market drug security. The agency, which will receive nearly $30 million annually under the plan, also intends to boost its communications and technological capabilities. (from FDANews by way of "The Pink Sheet" Daily)

---*Proteolix's Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma
Carfilzomib is a selective blocker of proteasome activity. (from the Earth Times)

---*IMF Chair Dr. Brian Durie is featured guest on a new satellite radio service for physicians: ReachMD, XM 157
The segment is called "New Treatments for Multiple Myeloma." ReachMD has provided the IMF with a direct link that does not require registration. However, we ask that you do register (it is free of charge), especially if you are a physician, to encourage future broadcasts on this topic. During the interview Dr. Durie addresses general practitioners about early warning signs that may indicate myeloma, and about the need for accurate diagnosis. He also explains how the "novel therapies," REVLIMID®, VELCADE® and THALOMID®, are changing the course of treatment.

---*Consensus on Care: New Insights on Novel Therapies in Multiple Myeloma
At the 33rd Annual Oncology Nursing Society Meeting in Philadelphia, PA, the IMF’s Nurse Leadership Board will present their key consensus recommendations to provide nurses with valuable clinical management tools for improving patient care at at a breakfast symposium on May 16, 2008.

---*How to Support a Loved One Reeling From Cancer Diagnosis
Even as the medical community has gotten better at detecting and treating cancer early -- allowing many patients to live longer -- people are understandably overwhelmed by the devastating news of a diagnosis. So family and friends grapple with how to best offer comfort. (from the Wall Street Journal by way of Yahoo Finance)

---*Cancer Treatment adds Years to Patients Lives
IMF Scientific Advisor Dr. Guido Tricot is featured in this short webcast from MyFox Utah.

---*Thalidomide Pharmion® Receives Marketing Approval from Australian Therapeutic Goods Administration for Treatment of Newly Diagnosed Multiple Myeloma
Approval is for use in combination with melphalan and prednisone for patients with untreated multiple myeloma or ineligible for high dose chemotherapy. Additionally, Thalidomide Pharmion was granted marketing approval in combination with dexamethasone for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. This represents the first oral cancer therapy ever registered for patients newly diagnosed with multiple myeloma in Australia. (from BusinessWire)"

Fin de la cita.
Saludos.

Gracias por el artículo Annie  

Un abrazo.

De nada!   
Lograste meterte en Myeloma Minute y leer los articulos "enteros"?(IMF)
Son 9 articulos, y no los copio integros por no aburrir a muchos,(porque lo malo es que son en inglés,como siempre!)
Antes mandaban "Mensajero" por E.Mail,con las mismas noticias que esas, pero en castellano..
Alguien  recibe "Mensajero",todavía?
Un abrazo.